28May 2022
Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study

Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study

Ethnicity is independently correlated with the clinical benefit and irAEs to anti‐PD‐1 monotherapy, and the differences in clinical benefit by ethnicity are attributed to melanoma subtypes but not irAEs. Caucasian ethnicity is independently associated with better ORR/PFS in NAC/UP but shared similar ORR/PFS in acral/mucosal/uveal melanomas. Caucasians had higher rates of GI but lower rates of endocrine/liver/other‐rare‐types of irAEs regardless of melanoma subtype.

  • #dermatology

Like

Save

Share